目前的神经成像方法,以区分帕金森病与其模仿者:成像特征和临床实践的影响
Mona Gad1,2, Francis Deng1, Jannik Prasuhn3,4,5,6,7
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, USA.
The neuroradiology journal
|February 9, 2026
概括
诊断帕金森病 (PD) 和其模仿的非典型帕金森综合征 (APS) 是一个挑战. 先进的神经成像,包括MRI和核医学,有助于区分PD与具有类似运动症状的疾病.
科学领域:
- 神经学 神经学
- 放射学 放射学是一门学科.
- 神经科学是一个神经科学.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,其特征是运动症状,如震和刚性,主要是由于多巴胺基神经元损失.
- 非典型帕金森综合征 (APS),包括MSA,PSP,DLB和CBD,与PD共享运动症状.
- 非神经退行性原因,如血管和药物诱导的帕金森症也模仿PD,使临床诊断复杂化.
研究的目的:
- 审查用于诊断PD的神经成像技术的最新进展.
- 探索MRI和核医学技术如何将PD与其模仿物区分开来.
- 要突出成像在识别APS特征性脑部变化的作用.
主要方法:
- 对PD和APS中神经成像的当前文献的综述.
- 专注于磁共振成像 (MRI) 技术.
- 强调核医学成像模式.
主要成果:
- 神经成像对于区分PD与其模仿者至关重要.
- 核磁共振和核医学揭示了不同的形态和代谢大脑变化.
- 这些技术显示出早期和准确诊断的潜力.
结论:
- 先进的神经成像对于区分PD与APS和其他帕金森综合征至关重要.
- 识别特定的结构和代谢标记有助于早期诊断.
- 最先进的成像技术提高了复杂病例的诊断准确性.
相关概念视频
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Brain Imaging
1.0K
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
1.0K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28


